High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.0M
$2,953,410
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
AQST
S
Aquestive Therapeutics, Inc.
Boyd Peter E.
• Officer • Chief People Officer
Sell to Cover
2026-03-10
$124,414
|
||||||
| AQST |
Aquestive Therapeutics, Inc.
|
Officer • Chief People Officer
Sell to Cover
|
2026-03-10 | $124,414 | S | Form 4 |
|
AQST
S
Aquestive Therapeutics, Inc.
TOTH A ERNEST JR
• CFO
Sell to CoverΔOwn -13.4%
2026-03-10
$243,094
|
||||||
| AQST |
Aquestive Therapeutics, Inc.
|
CFO
Sell to CoverΔOwn -13.4%
|
2026-03-10 | $243,094 | S | Form 4 |
| AQST |
Aquestive Therapeutics, Inc.
|
COO
Sell to CoverΔOwn -14.3%
|
2026-03-10 | $191,086 | S | Form 4 |
|
AQST
S
Aquestive Therapeutics, Inc.
Korczynski Sherry
• Officer • Chief Commercial Officer
Sell to Cover
2026-03-10
$65,687
|
||||||
| AQST |
Aquestive Therapeutics, Inc.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2026-03-10 | $65,687 | S | Form 4 |
|
AQST
S
Aquestive Therapeutics, Inc.
Cioffi Melina
• Officer • SVP, Regulatory Affairs
Sell to Cover
2026-03-10
$105,623
|
||||||
| AQST |
Aquestive Therapeutics, Inc.
|
Officer • SVP, Regulatory Affairs
Sell to Cover
|
2026-03-10 | $105,623 | S | Form 4 |
|
AQST
S
Aquestive Therapeutics, Inc.
BRAENDER LORI J
• Officer • Chief Legal Officer
Sell to Cover
2026-03-10
$167,346
|
||||||
| AQST |
Aquestive Therapeutics, Inc.
|
Officer • Chief Legal Officer
Sell to Cover
|
2026-03-10 | $167,346 | S | Form 4 |
|
AQST
S
Aquestive Therapeutics, Inc.
Barber Daniel
• CEO
Sell to CoverΔOwn -15.2%
2026-03-10
$753,965
|
||||||
| AQST |
Aquestive Therapeutics, Inc.
|
CEO
Sell to CoverΔOwn -15.2%
|
2026-03-10 | $753,965 | S | Form 4 |
| AQST |
Aquestive Therapeutics, Inc.
|
COO
10b5-1 SellΔOwn -21.9%
|
2025-10-15 | $473,701 | S | Form 4 |
|
AQST
S
Aquestive Therapeutics, Inc.
Kraus Carl N
• Officer • Chief Medical Officer
10b5-1 Sell
2025-10-15
$141,904
|
||||||
| AQST |
Aquestive Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-10-15 | $141,904 | S | Form 4 |
| AQST |
Aquestive Therapeutics, Inc.
|
COO
Other
|
2025-10-15 | $77,568 | M | Form 4 |
|
AQST
S
Aquestive Therapeutics, Inc.
Boyd Peter E.
• Officer • See Remarks
10b5-1 Sell
2025-10-15
$70,000
|
||||||
| AQST |
Aquestive Therapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-10-15 | $70,000 | S | Form 4 |
|
AQST
S
Aquestive Therapeutics, Inc.
Boyd Peter E.
• Officer • See Remarks
10b5-1 Sell
2025-09-26
$63,000
|
||||||
| AQST |
Aquestive Therapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-09-26 | $63,000 | S | Form 4 |
| AQST |
Aquestive Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-09-26 | $551,191 | S | Form 4 |
| AQST |
Aquestive Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-09-19 | $2,400 | S | Form 4 |